These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1792412)
1. Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe? Lai CK; Legge JS; Friend JA Respiration; 1991; 58(5-6):249-54. PubMed ID: 1792412 [TBL] [Abstract][Full Text] [Related]
2. Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study. Hall IP; Woodhead MA; Johnston ID Respiration; 1994; 61(4):214-8. PubMed ID: 7973107 [TBL] [Abstract][Full Text] [Related]
3. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. Crane J; Burgess CD; Graham AN; Maling TJ N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186 [TBL] [Abstract][Full Text] [Related]
4. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease. Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919 [TBL] [Abstract][Full Text] [Related]
6. Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. Poukkula A; Korhonen UR; Huikuri H; Linnaluoto M J Intern Med; 1989 Oct; 226(4):229-34. PubMed ID: 2681505 [TBL] [Abstract][Full Text] [Related]
7. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005 [TBL] [Abstract][Full Text] [Related]
8. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease. Filuk RB; Easton PA; Anthonisen NR Am Rev Respir Dis; 1985 Oct; 132(4):871-4. PubMed ID: 4051322 [TBL] [Abstract][Full Text] [Related]
9. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline. Whyte KF; Reid C; Addis GJ; Whitesmith R; Reid JL Br J Clin Pharmacol; 1988 May; 25(5):571-8. PubMed ID: 3408637 [TBL] [Abstract][Full Text] [Related]
10. Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease. Dickens GR; McCoy RA; West R; Stapczynski JS; Clifton GD Pharmacotherapy; 1994; 14(6):729-33. PubMed ID: 7885977 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD. Poole PJ; Saini R; Brodie SM; Black PN Respir Med; 2005 Mar; 99(3):372-6. PubMed ID: 15733514 [TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease. Cukier A; Vargas FS; Teixeira LR; Grupi CJ; Terra-Filho M; Carvalho-Pinto RM; Light RW Braz J Med Biol Res; 1994 Dec; 27(12):2869-77. PubMed ID: 7550007 [TBL] [Abstract][Full Text] [Related]
13. Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease. Edwards L; Perrin K; Williams M; Weatherall M; Beasley R Emerg Med J; 2012 Nov; 29(11):894-8. PubMed ID: 22158529 [TBL] [Abstract][Full Text] [Related]
14. Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Lipworth BJ; McDevitt DG; Struthers AD Br J Clin Pharmacol; 1989 Jun; 27(6):837-42. PubMed ID: 2547409 [TBL] [Abstract][Full Text] [Related]
15. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction. Crane J; Gamble S; Purdie G N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448 [TBL] [Abstract][Full Text] [Related]
16. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy]. Bossert J; Träger E Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475 [TBL] [Abstract][Full Text] [Related]
17. The hemodynamic effects of aminophylline and salbutamol alone and in combination. Burgess CD; Crane J; Graham AN; Maling TJ Clin Pharmacol Ther; 1986 Nov; 40(5):550-3. PubMed ID: 3533371 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Prendiville A; Green S; Silverman M Thorax; 1987 Feb; 42(2):86-91. PubMed ID: 3433245 [TBL] [Abstract][Full Text] [Related]
19. The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. Du Plooy WJ; Hay L; Kahler CP; Schutte PJ; Brandt HD Br J Pharmacol; 1994 Jan; 111(1):73-6. PubMed ID: 8012727 [TBL] [Abstract][Full Text] [Related]
20. The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease. Barclay J; Whiting B; Addis GJ Eur J Clin Pharmacol; 1982; 22(5):389-93. PubMed ID: 7117350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]